Related Experiment Video
Updated: May 3, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression
Kripa Patel1, Anita Kollory1, Asami Takashima1
1Cancer Center, Boston University School of Medicine, Boston, MA, United States.
Abstract:
Although dispensable for normal pancreatic function, STAT3 signaling is frequently activated in pancreatic cancers. Consistent downregulation of expression of microRNA let-7 is also characteristic of pancreatic ductal adenocarcinoma (PDAC) biopsy specimens. We demonstrate in this study that re-expression of let-7 in poorly-differentiated PDAC cell lines reduced phosphorylation/activation of STAT3 and its downstream signaling events and reduced the growth and migration of PDAC cells. Let-7 re-expression did not repress expression of STAT3 protein or its activator cytokine interleukin 6 (IL-6). However, let-7 re-expression enhanced cytoplasmic expression of suppressor of cytokine signaling 3 (SOCS3), which blocks STAT3 activation by JAK2. Our study thus identified a mechanism by which STAT3 signaling can be inhibited in pancreatic cancer cells by modifying let-7 expression.
Insights
Re-expressing microRNA let-7 in pancreatic cancer cells inhibits STAT3 signaling by increasing SOCS3. This reduces pancreatic ductal adenocarcinoma cell growth and migration, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Signal transducer and activator of transcription 3 (STAT3) signaling is often hyperactivated in pancreatic cancers.
- Downregulation of microRNA let-7 expression is a hallmark of pancreatic ductal adenocarcinoma (PDAC).
Purpose of the Study:
- To investigate the functional role of let-7 in regulating STAT3 signaling and PDAC progression.
- To elucidate the molecular mechanism by which let-7 influences STAT3 activation in pancreatic cancer cells.
Main Methods:
- Restoration of let-7 expression in poorly-differentiated PDAC cell lines.
- Analysis of STAT3 phosphorylation and downstream signaling.
- Assessment of PDAC cell growth and migration.
- Evaluation of STAT3 protein, IL-6, and SOCS3 expression levels.
Main Results:
- Re-expression of let-7 significantly reduced STAT3 phosphorylation and downstream signaling in PDAC cells.
- let-7 restoration decreased PDAC cell growth and migration.
- let-7 did not affect STAT3 or IL-6 expression but enhanced cytoplasmic SOCS3 expression.
- Increased SOCS3 expression by let-7 inhibited JAK2-mediated STAT3 activation.
Conclusions:
- let-7 acts as a tumor suppressor in PDAC by inhibiting STAT3 signaling through SOCS3.
- Modulating let-7 expression represents a potential therapeutic avenue for pancreatic cancer.
- The let-7/SOCS3/STAT3 axis offers a novel target for pancreatic cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The JAK-STAT Signaling Pathway

